Trademarkia Logo

Australia

AU$
Trademark Search
GVOKE HYPOPEN

View On IPO.GOV.AU

GVOKE HYPOPEN
Protected: Registered/protected

Last updated on 14 Apr 2021

Owner Info

Xeris Pharmaceuticals, Inc.

180 N LaSalle Street, Suite 1600

Chicago IL 60601, UNITED STATES OF AMERICA

Serial Number

2004049 filed on 19 Dec 2018

Correspondent

Tracy-Gene G. Durkin of Sterne, Kessler, Goldstein & Fox P.L.L.C.

1100 New York Avenue, NW,

Washington DC 20005,

UNITED STATES OF AMERICA

GVOKE HYPOPEN

Classification Information

Class [005]
Pharmaceutical products for the treatment of diabetes and metabolic diseases; pharmaceutical products for the treatment of diabetes and metabolic dise Read More

Mark Details

Serial Number

2004049

Registered On

19 Dec 2018

Renewal On

19 Dec 2028

Mark Type

WORD

Priority Claim (Convention Details)

Date

22 Jun 2018

Mark Type

US

Legal History

Show more

Status DateAction Taken
14th Apr 2021IP right goods and service classes updated
18th Jun 2020Amendment to International Registration Contact Requested
9th Apr 2020Amendment to Amend Owner Requested
11th Mar 2020Customer Amendment Made correspondence sent
10th Mar 2020Customer Amendment Made correspondence sent
11th Feb 2020Request Refused correspondence sent
11th Feb 2020Recording of Claimed Interest Requested
13th Dec 2019Recording of Claimed Interest Requested
16th Oct 2019International Registration in Australia Protected correspondence sent
15th Oct 2019IP Right Registration Published